SAR studies of o-hydroxychalcones and their cyclized analogs and study them as novel inhibitors of cathepsin B and cathepsin H

Cathepsins have emerged as a potential target for anti-cancer drug development. In the present study, we have synthesized three structurally related series of flavanoids i.e., 2′-hydroxychalcones, flavanones and flavones and assayed in vitro to study their inhibitory potency against cathepsin B and H, promising drug candidate for cancer therapy. Enzyme kinetics studies were carried out in presence of these compounds after preliminary proteolytic studies on endogenous protein substrates. SAR studies suggested that open chain flavanoids were better inhibitors as compared to their cyclized analogs. The most potent inhibitors among the three series were nitro substituted compounds 1g, 2g and 3g with Ki values of ∼6.18 × 10−8 M, 4.8 × 10−7 M and 7.85 × 10−7 M for cathepsin B and Ki values of ∼2.8 × 10−7 M, 31.8 × 10−6 M and 33.7 × 10−6 M for cathepsin H, respectively. The relationship between chalcone, flavanones and flavone structures interpreted by docking studies on cathepsin B and H also provided useful insights.

A comparative study is reported here in context with 2′-hydroxychalcones, flavanones and flavones as novel inhibitors of cathepsin B and cathepsin H and was found that open chain flavanoids were better inhibitors to both enzymes than their cyclized analogs.Figure optionsDownload high-quality image (64 K)Download as PowerPoint slide